Quick Answer
Citius Pharmaceuticals, Inc. reported Shares Outstanding of 18.07 million shares for fiscal year 2025.
Citius Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 18.07M | +149.3% |
| 2024 | 7.25M | +14.1% |
| 2023 | 6.35M | -95.7% |
| 2022 | 146.21M | +0.2% |
| 2021 | 145.98M | +162.7% |
| 2020 | 55.58M | +92.1% |
| 2019 | 28.93M | +78.6% |
| 2018 | 16.20M | +94.1% |
| 2017 | 8.35M | +71.2% |
| 2016 | 4.88M | -85.7% |
| 2015 | 34.12M | +13.6% |
| 2014 | 30.03M | +66.8% |
| 2013 | 18.00M | +0.0% |
| 2012 | 18.00M | +0.0% |
| 2011 | 18.00M | +0.0% |
| 2010 | 18.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 22.38M | +189.6% | +23.8% |
| September 30, 2025 | 18.07M | +149.3% | +24.8% |
| June 30, 2025 | 14.48M | -92.0% | +65.2% |
| March 31, 2025 | 8.76M | -94.5% | +13.4% |
| December 31, 2024 | 7.73M | -95.1% | +6.6% |
| September 30, 2024 | 7.25M | -95.4% | -96.0% |
| June 30, 2024 | 180.73M | +13.8% | +13.6% |
| March 31, 2024 | 159.09M | +8.7% | +0.1% |
- Citius Pharmaceuticals, Inc. showed an increase of +149.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Citius Pharmaceuticals, Inc.’s shares outstanding has grown by 0.4% (from 18.00 million shares to 18.07 million shares).
- The most recent figure is from Citius Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: